Reloxin May Be New Botox Alternative
Botox continues to be the most sought-after nonsurgical procedure for men and women interested in getting rid of wrinkles, and the FDA-approved injectable is a top choice for those pursuing the liquid facelift. Until now, Botox has dominated the dermal filler market, and the brand has even become a common household name. The FDA has recently announced its formal review of Reloxin, another anti-wrinkle injectable made with botulinum toxin.
Reloxin is currently owned by Medicis Pharmaceutical, and is making strides in receiving FDA approval for aesthetic use. Consumers outside of the United States are already testing Reloxin and enjoying the benefits of wrinkle-free skin; approval for Reloxin in the United States, however, may need to wait until 2009.
The Struggle for Reloxin in the U.S. Market
The Orange County Register reports that “Its corporate sponsors, Medicis Pharmaceutical of Scottsdale, Ariz., and Ipsen of Paris, announced today that they have refiled their application for Food and Drug Administration approval to market the wrinkle-fighting injectable drug in the United States. Medicis said it is hoping for FDA action on the application by early 2009."
According to William Phillip Wershcler, M.D., assistant clinical professor of medicine and dermatology at the University of Washington School of Medicine, Reloxin will set the stage for a ‘marketing war’ if it receives FDA approval. (Source: Cosmetic Surgery Times).
Botox works by ‘freezing’ and calming down the muscles in the treatment area, essentially preventing new wrinkles from forming and tightening up the skin in the process. It is a popular anti aging treatment, administered to reduce the appearance of deep grooves and wrinkles on the forehead and around the eyes. Some researchers suggest that Botox has other valuable uses, extending beyond its anti aging benefits. Botox has been administered to treat migraines, reduce underarm sweating, provide relief from neck pain, and even as part of a breast lift or breast enhancement procedure.
Latest News About Reloxin
Reloxin may offer similar benefits, but will primarily be a direct competitor of the brand, BOTOX as we know it today. Only a few small trials have been completed to date, and none of them have been conducted in the United States.
A press release about Ipsen, the company working with Medicis to get Reloxin approved for use in the U.S., reports that Reloxin has been approved for aesthetic use in the following countries: Argentina, Australia, Belarus, Brazil, Columbia, Ecuador, Egypt, Germany, Honduras, Israel, Kazakhstan, Mexico, Moldova, New Zealand, Philippines, Slovak Republic, Ukraine, Uruguay, Venezuela, Vietnam, and Russia. Consumers will need to wait until 2009 or later for Reloxin to receive FDA approval and enter the U.S. market, but may soon see more options for getting rid of deep creases and wrinkles.
Learn more about Botox and wrinkle treatments in our information guide, or consult with an anti aging specialist in your area to learn more about the treatment.